Stock Quote
AngioDynamics, Inc. (ANGO.O) (Nasdaq)
| Name | Current Position | Compensation |
|---|---|---|
| Bucci, Vincent | Chairman of the Board | 15,914 |
| Keltjens, Johannes | President, Chief Executive Officer, Director | 289,690 |
| Gersuk, D. Joseph | Chief Financial Officer, Executive Vice President, Treasurer | 593,452 |
Profile
Company Address
603 Queensbury Avenue
Queensbury NY 12804
P: +1518.7981215
F: +1518.7981360
Analyst Research
Performance of Key Competitors
| Company | Price | Change |
|---|---|---|
| Boston Scientific Corporation | $8.17 | +0.08 |
| Johnson & Johnson | $62.54 | +0.23 |
| C.R. Bard, Inc. | $80.92 | +0.20 |
| ANGO.O | Industry | |
|---|---|---|
| P/E(TTM) | 38.73 | 3.76 |
| P/S(TTM) | 1.97 | 0.51 |
| ROI(TTM) | 2.63 | 2.54 |
| ROE(TTM) | 2.70 | 4.01 |
| Consensus Recommendation | Hold |
|---|---|
| EPS Est. (Current Period) | 0.12 |
| EPS Est. (Current Year) | 0.51 |
| Total Revenue | $50.09M |
| Net Income | $2.11M |
| EPS | $0.09 |

